JPMORGAN CHASE & CO - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$4,394,645
-17.3%
481,869
-4.1%
0.00%
-100.0%
Q2 2023$5,315,931
-15.3%
502,451
-2.1%
0.00%0.0%
Q1 2023$6,277,000
+98316.4%
513,222
-0.1%
0.00%0.0%
Q4 2022$6,378
-99.9%
513,913
-6.3%
0.00%0.0%
Q3 2022$7,495,000
-27.2%
548,634
-2.3%
0.00%0.0%
Q2 2022$10,294,000
+692.5%
561,600
+595.5%
0.00%
Q1 2022$1,299,000
-12.5%
80,752
-23.9%
0.00%
Q4 2021$1,485,000
+42.9%
106,060
+91.1%
0.00%
Q3 2021$1,039,000
-12.6%
55,513
-2.6%
0.00%
Q2 2021$1,189,000
-21.5%
57,003
+6.5%
0.00%
Q1 2021$1,514,000
-47.7%
53,526
-39.6%
0.00%
Q4 2020$2,895,000
+148.7%
88,649
+132.7%
0.00%
Q3 2020$1,164,000
+89.0%
38,100
+0.9%
0.00%
Q2 2020$616,000
+83.9%
37,773
+12.4%
0.00%
Q1 2020$335,000
-59.3%
33,611
-43.9%
0.00%
Q4 2019$823,000
+45.4%
59,878
+60.5%
0.00%
Q3 2019$566,000
-14.4%
37,301
+11.6%
0.00%
Q2 2019$661,000
+474.8%
33,411
+384.0%
0.00%
Q1 2019$115,000
+13.9%
6,903
-4.5%
0.00%
Q4 2018$101,000
-12.2%
7,228
+10.3%
0.00%
Q3 2018$115,000
+25.0%
6,553
+29.8%
0.00%
Q2 2018$92,000
+13.6%
5,047
+16.5%
0.00%
Q1 2018$81,000
+3.8%
4,332
-14.3%
0.00%
Q4 2017$78,000
-90.3%
5,055
-90.9%
0.00%
Q3 2017$802,00055,4710.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders